Cambridge Epigenetix this week launched its TrueMethyl kits.
The products rely on oxidative bisulfite sequencing technology to support the repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine and methylcytosine, which is unachievable using traditional bisulfite sequencing, according to the UK company.
TrueMethyl kits can be used with next-generation sequencing systems, methylation arrays, and targeted assays, Cambridge Epigenetix said.